Search Results
Search results for "Institute for Research in Immunology and Cancer"
Results found for "Institute for Research in Immunology and Cancer"
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
For instance, aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative Neurochemical research, 42(1), 166–172. https://doi.org/10.1007/s11064-016-2026-6 Mendizabal-Zubiaga, GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic
- Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of...
macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer It has begun to play important roles in drug development for complex diseases such as cancer, including triple-negative breast cancer (TNBC). incorporated the dynamics of TAMs into our previously published QSP model to investigate their impact on cancer
- Emerging approaches for decoding neuropeptide transmission
November 2022 "Neuropeptides produce robust effects on behavior across species, and recent research has Current research has focused on isolating when and how neuropeptide transmission occurs, as well as the
- GRK2 in cardiovascular disease and its potential as a therapeutic target
advances in the field of pharmacological CVD treatments, particularly in the field of heart failure (HF) research Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus These data support the premise that GRK2 should be at the forefront of a novel investigative drug search functions of GRK2 in cardiac function and maladaptive pathology, and summarizes the ongoing and future research
- Understanding Biased Signaling in GPCRs
induced intracellular allosteric pocket, disrupting receptor–G protein interactions and abolishing constitutive live masterclasses, full replays, and access to the complete Masterclass Library, alongside curated research
- When the Assay Says Nothing, Look Again: Kinetic Detection of Multi-Target GPCR Activity
The Steady-State Cancellation Problem A scaffold carrying both agonist and antagonist activity presents Nothing in the steady-state result signals that two active processes are cancelling each other. At steady state, the effects cancel, and the compound appears to have no net action. scaffold that reads as inactive under standard screening conditions may carry multiple activities that are cancelling
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Explore this week’s research, tools, and biotech insights in one place.
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
Explore this week’s research, tools, and biotech insights in one place.
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
since they are able to adopt an active conformation without agonist engagement referred to as receptor constitutive The initial demonstration of spontaneous or "constitutive" receptor activity was reported for the β2- Subsequently, opioid receptors were shown to constitutively activate Gi proteins in a membrane preparation activity, and can compete with agonist ligands; 4) and inverse agonists decrease the level of receptor constitutive GPCRs functional selectivity Recent research has revealed a more intricate understanding of GPCR behavior
- Addex Raises $10 Million In Equity Financing
announced that it has entered into a definitive agreement with Armistice Capital LLC, a healthcare-focused institutional
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
GPCR research requires turning data into insights for drug discovery Hi GPCR Friends, Every week, critical decisions in GPCR research hinge on subtle shifts in data.
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Prior to this, Professor Deane was Deputy Executive Chair of the Engineering and Physical Sciences Research Council at UK Research and Innovation (UKRI).
- Quantifying Receptor Selectivity in Modern Drug Discovery
In this session, you’ll gain: A framework for cancelling cell effects to isolate true receptor selectivity distinction between receptor selectivity and signaling bias Quantifying Receptor Selectivity Requires Canceling can appear to differ by thousands-fold in selectivity—until the system contribution is mathematically cancelled Canceling the Cell If observed potency reflects both drug properties and system sensitivity, then system across two receptor systems—and then comparing those ratios to each other—system-dependent factors cancel
- New Podcast, Sweet Structures & $2.2B GPCR Moves
Explore this week’s research, tools, and biotech insights in one place.
- Addex raises $4.2 million in equity financing
that it has entered into a definitive agreement with Armistice Master Fund LTV, a healthcare-focused institutional
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
Thus, the aim of the current research was to explore the influence of CB1 receptor stimulation and inhibition The present research demonstrated that 10 nM of ACEA notably amplified mRNA gene expression of NR4A1 Further research is required to fully delineate their role(s)."
- đź§ Do you want to share your #GPCR knowledge?
GPCR Ecosystem and create a course on your favorite #GPCR research, technique and more… Available for
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
chemistry, and drug discovery —rethinking how simulations, docking, and machine learning can transform GPCR research But success depends on researchers who can manage expectations, build trust, and integrate across disciplines
- Join Dr. GPCR Summit 2022 in 3 simple steps!
Come join us from October 10 to 16 to hear about exciting #GPCR research from amazing speakers.
- Dr. GPCR Virtual Cafe with Matthew Eddy - New date!
Don't miss the chance to listen to his latest research on the field.
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Our PKC KO cell lines expand the repertoire of KO HEK293A cell lines available to research GPCR pharmacology isozymes generally lack specificity and/or potency, we present the PKC KO cell lines as more specific research
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
understanding of psychedelic pharmacology is derived from rodent models, but most of this preclinical research mice, and support the importance of studying sex as a biological variable in preclinical psychedelic research
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Explore this week’s research, tools, and biotech insights in one place.
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
objective is straightforward: Make mechanistic pharmacology easier to access, revisit, and apply across research
- A cryptic mode of GPCR regulation revealed
October 2022 "Over three decades of research have provided thorough insights into G protein-coupled receptor
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Research using techniques like bioluminescence resonance energy transfer (BRET) and fluorescence resonance In summary, dimerization in class B1 GPCRs is an emerging area of research that has far-reaching implications
- Novo Nordisk moves to strengthen obesity efforts
Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Institutional and team memberships receive discounted rates to support coordinated participation.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Inverse Agonists and Hemi-Equilibria In systems with constitutive receptor activity , inverse agonists It encourages skepticism—forcing researchers to prove competition before quantifying it.
- Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca 2+ Sensing but...
Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)."















